Next Quarterly Earnings
Date confirmed from the official Chinese exchange disclosure timetable.
Walvax Biotechnology A, a leading Chinese enterprise, specializes in the research, development, and manufacturing of vaccines and innovative biopharmaceutical products. Through advanced biotechnology, the company actively contributes to global health, offering high-quality medical solutions. Its focus is on innovation and patient safety.
Date confirmed from the official Chinese exchange disclosure timetable.
Walvax Biotechnology A is scheduled to report its next quarterly earnings on 08/29/2026.
Walvax Biotechnology A last reported quarterly earnings on 4/24/2026 (Q1 2026). Earnings per share (EPS) came in at 0.07 CNY.
Across its last 3 earnings reports, Walvax Biotechnology A stock moved by ±1.5% on average the following day. The largest reaction was +3.9% on 03/27/2026; 2 of 3 reactions were positive.
Walvax Biotechnology A has beaten analyst EPS estimates in 2 of its last 4 evaluated quarters (beat rate: 50%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 3 report dates (close to close).
Basis: 4 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.